Global Health Economics and Outcomes Research Services Market Size & Trends Report Segmented by Service Type (Economic Modelling & Evaluation, Real World Data, Market Access), Service Provider (CRO, Consultancy), End-user & Regional Forecast to 2030
The global health economics and outcomes research services market is expected to grow at a CAGR of ~13% during the forecast period. Increase in R&D spending by the pharmaceutical and biotech companies, growing demand for real-world evidence, rising focus on value-based care models, and increasing awareness of the importance of health economics and outcomes research services are some of the key factors driving the market growth. However, limited access to real-world data and the high cost of research remains major constraints for the health economics and outcomes research services market growth. To learn more about the research report, download a sample report.
Overview
Health economics and outcomes research (HEOR) services play a key role in the healthcare industry by helping different stakeholders understand the real value of medical products and treatments. HEOR services include evaluation of the economic value, clinical outcome assessment, and how effective a treatment is, and how it affects patients' daily lives. These insights are especially important today as healthcare systems focus more on improving patient outcomes while also controlling costs.
In healthcare industry that is increasingly shifting toward value-based care and outcome-driven reimbursement models, HEOR has become essential for demonstrating the value proposition of drugs, medical devices, and healthcare services. Governments and insurance providers rely on HEOR evidence to make informed decisions about pricing, reimbursement, and coverage, while pharmaceutical and biotech companies use HEOR data to support market access, regulatory submissions, and health technology assessments (HTAs). With the rising demand for cost-effective and patient-centric care, the HEOR services market is gaining traction globally.
To learn more about this report, download the PDF brochure
Expanding role of real-world evidence in healthcare evaluation
One of the primary drivers contributing to the growth of the HEOR services market is the increasing demand for real-world evidence (RWE). RWE is derived from clinical data collected from everyday medical practice, including electronic health records (EHRs), insurance claims, patient registries, and digital health apps. Unlike clinical trials, RWE reflects on the effectiveness, safety, and usage of medical interventions across diverse patient populations in everyday clinical practice.
As healthcare systems globally transition toward value-based care and personalized medicine, stakeholders such as regulatory agencies, healthcare payers, and providers rely on RWE to support decision-making. For instance, in December 2024, the US FDA’s Center for Drug Evaluation and Research (CDER) established the Center for Real-World Evidence Innovation (CCRI), which is set up to improve the quality, collection, and application of RWE in regulatory decision-making. This growing demand for RWE significantly strengthens the position of HEOR as a critical component in shaping effective, evidence-based healthcare policies and practices. For instance, in October 2023, Curavit, a virtual contract research organization (VCRO) specializing in decentralized clinical trials (DCTs) for digital therapeutics (DTx), launched its dedicated HEOR Practice, intended to meet the growing demand for real-world evidence by integrating HEOR services into clinical trials.
Integration of AI and analytics enhances HEOR methodologies
Advanced analytics allows accurate forecasting, segmentation, and cost-effectiveness modelling by leveraging large-scale datasets, including RWE, EHRs, and insurance claims. AI, particularly machine learning (ML) and natural language processing (NLP), supports automated data processing, pattern recognition, and predictive modelling, which is improving the speed, precision, scalability and reducing manual errors.
The increasing adoption of advanced analytics and artificial intelligence (AI) is emerging as a significant trend in the HEOR services market. As healthcare data becomes more complex and voluminous, traditional analytical methods are no longer sufficient to extract meaningful insights efficiently. To address this, HEOR service providers are integrating advanced analytical tools and AI technologies to enhance data interpretation, model development, and decision-making processes. For instance, in September 2024, IQVIA launched its AI Assistant, a smart, conversational tool that helps life sciences professionals quickly analyze healthcare data, identify patient cohorts, and generate predictive insights to support faster, smarter decision-making.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global health economic and outcomes research services market is marked by the presence of established and emerging market players such as McKesson Corporation; IQVIA Inc.; ICON plc.; Syneos Health, Inc.; Medlior Health Outcomes Research Ltd.; Paraxel International Corporation; Axtria Inc.; Cardinal Health Inc.; Optum Inc.; and Avalon Health Economics LLC; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 – 2030 |
| Growth Rate | ~13% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Service Type, Service Provider, and End-user |
| Regional Scope |
|
| Key Companies Mapped | McKesson Corporation; IQVIA Inc.; ICON plc.; Syneos Health, Inc.; Medlior Health Outcomes Research Ltd.; Paraxel International Corporation; Axtria Inc.; Cardinal Health Inc.; Optum Inc.; and Avalon Health Economics LLC; among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Â
Global Health Economics and Outcomes Research Services Market Segmentation
This report by Medi-Tech Insights provides the size of the global health economics and outcomes research services market at the regional- and country-level from 2023 to 2030. The report further segments the market based on service type, service provider, and end-user.
Market Size & Forecast (2023-2030), By Service Type, USD Million
- Economic Modelling & Evaluation
- Real World Data Analysis
- Market Access Solutions
- Clinical Outcome Assessment
- Others
Market Size & Forecast (2023-2030), By Service Provider, USD Million
- Contract Research Organizations
- Consultancy
Market Size & Forecast (2023-2030), By End-user, USD Million
- Pharma and Biotech Companies
- Government Organizations
- Healthcare Providers
- Healthcare Payers
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the health economics and outcomes research services market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the health economics and outcomes research services market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction​
- Market Scope​
- Market Definition​
- Segments Covered​
- Regional Segmentation​
- Research Timeframe​
- Currency Considered​
- Study Limitations​
- Stakeholders​
- List of Abbreviations​
- Key Conferences and Events (2025-2026)​
- Research Methodology​
- Secondary Research​
- Primary Research​
- Market Estimation​
- Bottom-Up Approach​
- Top-Down Approach​
- Market Forecasting​
- Executive Summary
- Health Economics and Outcomes Research (HEOR) Services Market Snapshot (2025-2030)​
- Segment Overview​
- Regional Snapshot​
- Competitive Insights ​
- Market Overview
- Market Dynamics
- Drivers
- Increasing R&D spending by pharma and biotech companies
- Growing demand for real-world evidence
- High prevalence of chronic diseases
- Shift toward value-based healthcare
- Increasing regulatory reliance on HEOR in pricing and access
- AI and advanced analytics improving HEOR capabilities
- Restraints​
- Limited access to structured real-world data
- High cost of research services
- Variability in global regulatory landscape
- Opportunities​
- Rising clinical trials and drug approvals
- Collaborations between payers, providers, and life sciences
- AI-powered HEOR platforms for faster, scalable insights
- Expansion into emerging markets
- Key Market Trends​
- Use of AI assistants to accelerate HEOR data analysis
- Inclusion of patient-reported outcomes in HEOR frameworks
- Unmet Market Needs​
- Industry Speaks​
- Drivers
- Market Dynamics
- Global Health Economics and Outcomes Research Services Market Size & Forecast (2023-2030), By Service Type, USD Million
- Introduction
- Economic Modelling & Evaluation Services
- Real World Data Analysis
- Market Access Solution
- Clinical Outcome Assessment
- Others
- Global Health Economics and Outcomes Research Services Market Size & Forecast (2023-2030), By Service Provider, USD Million
- Introduction
- Contract Research Organizations
- Consultancy
- Global Health Economics and Outcomes Research Services Market Size & Forecast (2023-2030), By End-user, USD Million
- Introduction
- Pharma and Biotech Companies
- Government Organizations
- Healthcare Provider
- Healthcare Payers
- Others
- Global Health Economics and Outcomes Research Services Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction​
- North America Health Economics and Outcomes Research Services Market Size & Forecast (2023-2030), By Country, USD Million​
- US​
- Market Size & Forecast, By Service Type (USD Million)​
- Market Size & Forecast, By Service Provider (USD Million)​
- Market Size & Forecast, By End-user (USD Million)​​
- Canada​
- Market Size & Forecast, By Service Type (USD Million)​
- Market Size & Forecast, By Service Provider (USD Million)​
- Market Size & Forecast, By End-user (USD Million)​​
- US​
- Europe Health Economics and Outcomes Research Services Market Size & Forecast (2023-2030), By Country, USD Million​
- UK ​
- Market Size & Forecast, By Service Type (USD Million)​
- Market Size & Forecast, By Service Provider (USD Million)​
- Market Size & Forecast, By End-user (USD Million)​​
- Germany ​
- Market Size & Forecast, By Service Type (USD Million)​
- Market Size & Forecast, By Service Provider (USD Million)​
- Market Size & Forecast, By End-user (USD Million)​​
- France​
- Market Size & Forecast, By Service Type (USD Million)​
- Market Size & Forecast, By Service Provider (USD Million)​
- Market Size & Forecast, By End-user (USD Million)​​
- Italy ​
- Market Size & Forecast, By Service Type (USD Million)​
- Market Size & Forecast, By Service Provider (USD Million)​
- Market Size & Forecast, By End-user (USD Million)​​
- Spain ​
- Market Size & Forecast, By Service Type (USD Million)​
- Market Size & Forecast, By Service Provider (USD Million)​
- Market Size & Forecast, By End-user (USD Million)​​
- Rest of Europe ​
- Market Size & Forecast, By Service Type (USD Million)​
- Market Size & Forecast, By Service Provider (USD Million)​
- Market Size & Forecast, By End-user (USD Million)​​
- UK ​
- Asia Pacific (APAC) Health Economics and Outcomes Research Services Market Size & Forecast (2023-2030), By Country, USD Million​
- China ​
- Market Size & Forecast, By Service Type (USD Million)​
- Market Size & Forecast, By Service Provider (USD Million)​
- Market Size & Forecast, By End-user (USD Million)​​
- Japan ​
- Market Size & Forecast, By Service Type (USD Million)​
- Market Size & Forecast, By Service Provider (USD Million)​
- Market Size & Forecast, By End-user (USD Million)​​
- India ​
- Market Size & Forecast, By Service Type (USD Million)​
- Market Size & Forecast, By Service Provider (USD Million)​
- Market Size & Forecast, By End-user (USD Million)​​
- Rest of Asia Pacific ​
- Market Size & Forecast, By Service Type (USD Million)​
- Market Size & Forecast, By Service Provider (USD Million)​
- Market Size & Forecast, By End-user (USD Million)​​
- China ​
- Latin America (LATAM) Health Economics and Outcomes Research Services Market Size & Forecast (2023-2030), USD Million​
- Market Size & Forecast, By Service Type (USD Million)​
- Market Size & Forecast, By Service Provider (USD Million)​
- Market Size & Forecast, By End-user (USD Million)​​​
- Middle East & Africa (MEA) Health Economics and Outcomes Research Services Market Size & Forecast (2023-2030), USD Million​
- Market Size & Forecast, By Service Type (USD Million)​
- Market Size & Forecast, By Service Provider (USD Million)​
- Market Size & Forecast, By End-user (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product & Service Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- McKesson Corporation
- IQVIA Inc.
- ICON plc.
- Syneos Health
- Medlior Health Outcomes Research Ltd.
- Paraxel International
- Axtria Inc.
- Cardinal Health Inc.
- Optum Inc.
- Avalon Health Economics LLC
- Other Prominent Players
Note: *Indicative list
**For listed companiesÂ
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Pharma and Biotech Companies, Government Organizations, and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
Features of the Report
- Comprehensive Market Coverage
- Market Size and Forecast
- Geographic & Segment Deep Dives
- Strategic Insights & Competitive Landscape
- Timely & Updated Data
- Growth Indicators & Future Outlook
- Quick Turnaround on Queries
- Analyst Support
- Report Customization Available
- Reports in PDF & Excel
